期刊文献+

糖尿病治疗新进展 被引量:2

下载PDF
导出
摘要 糖尿病是由多种病因引起以慢性高血糖为特征的代谢紊乱。高血糖是由于胰岛素分泌或作用的缺陷,或者两者同时存在而引起。除碳水化合物外,尚有蛋白质、脂肪代谢异常,采取的对症治疗方式是降血糖的方法,这种方法可以控制血糖指标,但患者要终生服药而且随着病情的发展会产生高血压、冠心病、高血脂、视网膜病变、糖尿病肾病及病足等并发症[2]。糖尿病目前虽还没有根治方法,但绝不是不治之症。
作者 韩平
出处 《内蒙古中医药》 2014年第1期121-121,共1页 Inner Mongolia Journal of Traditional Chinese Medicine
  • 相关文献

参考文献2

二级参考文献30

  • 1Tourrel C, Bailbe D, Meile MJ, et al. Glucagon-like peptide-1 and exendin-4 stimulate β-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes, 2001,50:1562-1570.
  • 2Egan JM, Bulotta A, Hui H, et al. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. Diabetes Metab Res Rev,2003,19:115-123.
  • 3Brubaker PL, Drucker DJ. Structure function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1 and GLP-2 receptors. Recep Chan,2002,8:179-188.
  • 4Holst JJ. Therapy of type 2 diabetes mellitus based on the action of glucagon-like peptide-1. Diabetes Metab Res Rev,2002,18:430-441.
  • 5Zander M, Madsbad S, Madsen JL, et al. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity and β-cell function in type 2 diabetes: a parallel-group study. Lancet, 2002,359: 824-830.
  • 6Nielsen LL, Young AA, Parkes DG. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes. Regul Pept,2004,117:77-88.
  • 7Abraham EJ, Leech CA, Lin JC, et al. Insulinotropic hormone glucagonlike peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology,2002,143:3152-3161.
  • 8Zhou J, Wang X, Pineyro MA, et al. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes, 1999,48:2358-2366.
  • 9Xu G, Stoffers DA, Habener JF, et al. Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes,1999,48:2270-2276.
  • 10Tourrel C, Bailbe D, Lacorne M, et al. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the β-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes,2002,51:1443-1452.

共引文献13

同被引文献37

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部